Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Growth (Status and Outlook) 2025-2031

According to this study, the global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market size will reach US$ million by 2031.

Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Industry Forecast” looks at past sales and reviews total world Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics sales for 2025 through 2031. With Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Hydrogen-predominant SIBO
Methane-predominant SIBO
Recurrent SIBO

Segmentation by Application:
Hospitals
Physician Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genova Diagnostics
SIBO Diagnostics
Commonwealth Diagnostics International
Aerodiagnostics, LLC
SIBOTest
Metabolic Solutions, Inc.
Pivotal Diagnostics
DirectLabs, LLC
Vibrant Wellness
Health Associates Medical Group

Please note: The report will take approximately 2 business days to prepare and deliver. Show more